CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-01 | Schlanger David J Chief Executive Officer | Exercise or conversion · Employee Stock Option (right to buy) | −50,000 | 2,784,384 | ||
| 2021-09-01 | Payson Norman Director | Sale | −4,747 | $55.85 | $265K | 784,159 |
| 2021-09-01 | Payson Norman Director | Sale | −3,583 | $56.41 | $202K | 780,576 |
| 2021-09-01 | Livingston Mark S. Chief Financial Officer | Grant or award | +75,000 | 90,348 | ||
| 2021-09-01 | Livingston Mark S. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2021-08-26 | Schlanger David J Chief Executive Officer | Exercise or conversion | +34,691 | $0.91 | $32K | 34,691 |
| 2021-08-26 | Schlanger David J Chief Executive Officer | Sale | −34,691 | $51.61 | $1.8M | 0 |
| 2021-08-26 | Schlanger David J Chief Executive Officer | Exercise or conversion · Employee Stock Option (right to buy) | +34,691 | 2,834,384 | ||
| 2021-08-26 | Payson Norman Director | Sale | −8,289 | $51.46 | $427K | 788,947 |
| 2021-08-26 | Payson Norman Director | Sale | −41 | $51.85 | $2K | 788,906 |
| 2021-08-25 | Schlanger David J Chief Executive Officer | Exercise or conversion | +115,309 | $0.91 | $105K | 115,309 |
| 2021-08-25 | Schlanger David J Chief Executive Officer | Sale | −106,808 | $51.70 | $5.5M | 8,501 |
| 2021-08-25 | Schlanger David J Chief Executive Officer | Sale | −8,501 | $52.20 | $444K | 0 |
| 2021-08-25 | Schlanger David J Chief Executive Officer | Exercise or conversion · Employee Stock Option (right to buy) | +115,309 | 2,869,075 | ||
| 2021-08-25 | Payson Norman Director | Sale | −6,150 | $51.55 | $317K | 799,416 |
| 2021-08-25 | Payson Norman Director | Sale | −2,180 | $51.91 | $113K | 797,236 |
| 2021-08-12 | Payson Norman Director | Sale | −8,330 | $46.56 | $388K | 822,226 |
| 2021-08-11 | Payson Norman Director | Sale | −6,271 | $45.65 | $286K | 832,615 |
| 2021-08-11 | Payson Norman Director | Sale | −2,059 | $46.14 | $95K | 830,556 |
| 2021-08-05 | Payson Norman Director | Sale | −2,600 | $54.01 | $140K | 844,616 |
Page 72 of 77 · 1,524 trades